PMID: 9554245Apr 29, 1998Paper

Oral contraceptive use and benign gynecologic conditions. A review

Contraception
Francesca ChiaffarinoPier Giorgio Crosignani

Abstract

The following review considers the main epidemiologic data on oral contraceptives (OC) and the risk of major benign gynecologic diseases. Earlier studies investigating the relationship between OC use and functional ovarian cysts indicated that the use of high-dose combination OC have a protective effect, whereas low-dose monophasic or multiphasic pills have little or no effect. With regard to seromucinous cysts, the scanty data available are consistent with the notion of some protection of OC in current but not in former users, although possible effects of diagnostic and selection bias should be considered. Published data on the relationship between fibroids and OC appear too scattered to allow a precise quantification of risk. In any case, any relationship is moderate and, hence, of limited clinical and public health relevance. The data on OC and benign gynecologic conditions are reassuring in their absence of any consistent excess risk.

References

May 21, 1977·Lancet·O Ylikorkala
Oct 1, 1992·Journal of Epidemiology and Community Health·M BoothC Scott
Mar 1, 1992·American Journal of Obstetrics and Gynecology·S F LanesS Singer
Mar 1, 1992·Obstetrics and Gynecology·F ParazziniL Luchini
Mar 1, 1989·International Journal of Epidemiology·F ParazziniG Cecchetti
Sep 27, 1986·British Medical Journal·C La VecchiaS Franceschi
Jun 13, 1987·British Medical Journal·M VesseyD Yeates
Jun 1, 1987·American Journal of Obstetrics and Gynecology·J C Caillouette, A L Koehler
Jan 1, 1987·Acta Obstetricia Et Gynecologica Scandinavica·M H Moen
Jun 1, 1995·Obstetrics and Gynecology·H Sangi-Haghpeykar, A N Poindexter
Jan 1, 1994·Contraception·F ParazziniC La Vecchia
Jan 16, 1993·BMJ : British Medical Journal·M P VesseyR Painter
Mar 1, 1993·Epidemiology·S L DarrowS Selman
Jun 1, 1996·American Journal of Public Health·A R SamadiE B Parris
Sep 1, 1996·Epidemiology·F ParazziniE Ricci
Oct 1, 1996·The Journal of Family Practice·K H Johnson, P S Millard
Aug 1, 1997·Journal of Epidemiology and Community Health·F ParazziniP G Crosignani
Jul 25, 1998·The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception·P G CrosignaniD Bianchedi

❮ Previous
Next ❯

Citations

Jan 12, 2007·Cancer Causes & Control : CCC·Suzanne G FolgerRobert Spirtas
Aug 9, 2003·Obstetrics and Gynecology·Victoria L HoltJanet R Daling
Aug 24, 1999·British Journal of Obstetrics and Gynaecology·F ChiaffarinoE Ricci
Nov 1, 2006·Women's Health·Tony Bazi, Tony G Zreik
May 25, 2011·Obstetrics and Gynecology·James H Liu, Kristine M Zanotti
May 20, 2008·Obstetrics and Gynecology Clinics of North America·Michael P Stany, Chad A Hamilton
Jun 7, 2008·Best Practice & Research. Clinical Obstetrics & Gynaecology·Stanley Okolo
Sep 25, 2007·Medical Hypotheses·V L KodatiQ Hasan
Feb 13, 2010·The Journal of Obstetrics and Gynaecology Research·Sunduz Ozlem AltinkayaCavidan Gulerman
Oct 2, 2002·Obstetrics and Gynecology Clinics of North America·J Kell Williams
Apr 24, 2004·American Journal of Obstetrics and Gynecology·Ronald BurkmanMiriam Zieman
Feb 24, 2001·Toxicologic Pathology·K D HoustonC L Walker
May 2, 2014·The Cochrane Database of Systematic Reviews·David A GrimesKenneth F Schulz
Oct 19, 2004·Acta Obstetricia Et Gynecologica Scandinavica·Ulla Breth KnudsenOle Mogensen
Dec 26, 2017·Current Obstetrics and Gynecology Reports·Parveen ParasarKathryn L Terry
Feb 24, 2001·The Medical Journal of Australia·I S Fraser

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.